FKBP3 and disease arising from reactivation of latent virus: To directly test whether FKBP3 promotes HIV-1 latency in primary human CD4+ T lymphocytes, we established a primary HIV-1 latent infection model as described before (45, 46) (Fig. 4A) (primary CD4+ T lymphocyte cells from three donors).